Mizuho Securities Downgrades AmSurg (AMSG) to Neutral Following Trump Win
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Mizuho Securities downgraded AmSurg (NASDAQ: AMSG) from Buy to Neutral with a price target of $71.00 following Trump win.
Analyst Ann Hynes commented, "We are downgrading our ACA vulnerable stocks (UHS, AMSG and MD) to Buy from Neutral given President-elect Trump's pledge to repeal and replace Obamacare. Even though it is yet seen if he will be able to claw back an entitlement as big as Obamacare, the fear itself will weigh on valuations and, as a result, we no believe these stocks can outperform until we receive clarity on his true intentions."
Shares of AmSurg closed at $67.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: BMO Capital Upgrades Williams Partners LP (WPZ) to Outperform
- Credit Suisse Starts BioMarin Pharmaceutical Inc. (BMRN) at Outperform, Says Next Gen Disease Treaments Drive 2017 Bull Outlook
- Morgan Stanley Upgrades TIM Participacoes (TSU) to Overweight
Create E-mail Alert Related CategoriesAnalyst Comments, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!